1832 Asset Management L.P. lessened its stake in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 29.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,918 shares of the company's stock after selling 24,545 shares during the quarter. 1832 Asset Management L.P.'s holdings in Keurig Dr Pepper were worth $2,050,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of KDP. ST Germain D J Co. Inc. acquired a new stake in shares of Keurig Dr Pepper in the 1st quarter valued at $27,000. Continuum Advisory LLC lifted its holdings in Keurig Dr Pepper by 82.5% during the 1st quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock valued at $46,000 after purchasing an additional 602 shares during the last quarter. Global Trust Asset Management LLC bought a new position in Keurig Dr Pepper during the 1st quarter valued at about $48,000. LRI Investments LLC boosted its position in Keurig Dr Pepper by 65.6% in the fourth quarter. LRI Investments LLC now owns 1,527 shares of the company's stock valued at $49,000 after buying an additional 605 shares in the last quarter. Finally, Riverview Trust Co grew its stake in Keurig Dr Pepper by 47.7% during the first quarter. Riverview Trust Co now owns 1,710 shares of the company's stock worth $59,000 after buying an additional 552 shares during the last quarter. 93.99% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Keurig Dr Pepper
In other news, Director Robert James Gamgort sold 7,601 shares of Keurig Dr Pepper stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $35.91, for a total transaction of $272,951.91. Following the transaction, the director directly owned 2,284,568 shares of the company's stock, valued at $82,038,836.88. This trade represents a 0.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of the business's stock in a transaction on Thursday, July 17th. The shares were sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the transaction, the insider directly owned 82,511 shares of the company's stock, valued at $2,777,320.26. This trade represents a 12.70% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 679,601 shares of company stock valued at $22,508,712. Corporate insiders own 0.40% of the company's stock.
Keurig Dr Pepper Trading Down 0.7%
KDP traded down $0.20 during midday trading on Friday, reaching $29.09. 22,200,454 shares of the company were exchanged, compared to its average volume of 12,628,653. The stock has a market capitalization of $39.52 billion, a P/E ratio of 25.97, a PEG ratio of 1.63 and a beta of 0.45. Keurig Dr Pepper, Inc has a one year low of $28.70 and a one year high of $38.28. The stock's 50-day simple moving average is $33.45 and its 200 day simple moving average is $33.60. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.40 and a current ratio of 0.64.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, meeting analysts' consensus estimates of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The company had revenue of $4.16 billion during the quarter, compared to analysts' expectations of $4.14 billion. During the same period in the prior year, the business posted $0.45 EPS. Keurig Dr Pepper's revenue was up 6.1% on a year-over-year basis. As a group, analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on KDP shares. HSBC reiterated a "hold" rating and issued a $30.00 target price (down previously from $42.00) on shares of Keurig Dr Pepper in a research note on Tuesday. Hsbc Global Res cut Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a report on Tuesday. Jefferies Financial Group set a $41.00 price objective on Keurig Dr Pepper in a research report on Monday. Barclays boosted their price objective on Keurig Dr Pepper from $37.00 to $39.00 and gave the stock an "overweight" rating in a research note on Monday, July 28th. Finally, UBS Group lowered their target price on Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a research note on Wednesday. Eleven analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $38.38.
Check Out Our Latest Research Report on Keurig Dr Pepper
About Keurig Dr Pepper
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Read More

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.